The Trump administration’s proposal to require prescription drug manufacturers to disclose prices in TV ads may be primed for legal challenges.
The rule proposed Monday would require ads for drugs paid for by Medicare or Medicaid to include the “list price” or Wholesale Acquisition Cost for products costing more than $35 for a month’s supply.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,